发明名称 CRYSTALLINE R-(R*,R*))-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL)-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN)
摘要 <p>There are described novel crystalline forms of ÄR-(R*,R*)Ü-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-Ä(phenylamino)carbonylÜ-1H-pyr role-l-heptanoic acid hemi calcium salt designated Form II and Form IV which are characterized by their X-ray powder diffraction and/or solid state NMR, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia and hypercholesterolemia.</p>
申请公布号 SI848705(T1) 申请公布日期 2002.04.30
申请号 SI19960030355T 申请日期 1996.07.08
申请人 WARNER-LAMBERT COMPANY 发明人 BRIGGS CHRISTOPHER A.;JENNINGS REX ALLEN;WADE ROBERT A.;HARASAWA KIKUKO;ICHIKAWA SHIGERU;MINOHARA KAZUO;NAKAGAWA SHINSUKE
分类号 C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):C07D207/34 主分类号 C07D207/34
代理机构 代理人
主权项
地址